Showing results (1151-1160 of 1,686) with videos related to

Sort By:
Pageof 169
Heart (British Cardiac Society)|September 17, 2003
Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trialsH S Gurm, D L Bhatt, A M Lincoff, et al.
Circulation. Cardiovascular Interventions|October 25, 2012
Repeat revascularization after contemporary percutaneous coronary intervention: an evaluation of staged, target lesion, and other unplanned revascularization procedures during the first yearJoshua M Stolker, David J Cohen, Kevin F Kennedy, et al.
Scientific Reports|August 20, 2024
BAX and DDB2 as biomarkers for acute radiation exposure in the human blood ex vivo and non-human primate modelsKarthik Kanagaraj, Michelle A Phillippi, Elizabeth H Ober, et al.
JACC. Case Reports|October 4, 2023
TAV-in-TAV in Failed Homograft: Redo TAVI in a Patient With 3 Previous SternotomiesTaha Hatab, Syed Zaid, Priscilla Wessly, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 26, 2024
Abbreviated ticagrelor based dual antiplatelet therapy in acute coronary syndrome: A systematic review and meta-analysisWissam Harmouch, Ravi Thakker, Mirza Umair Khalid, et al.
Autism : the International Journal of Research and Practice|July 27, 2023
The emotional support plan: Feasibility trials of a brief, telehealth-based mobile intervention to support coping for autistic adultsVanessa H Bal, Annabelle M Mournet, Tori Glascock, et al.
Circulation. Cardiovascular Interventions|June 15, 2016
Early Recovery of Left Ventricular Systolic Function After CoreValve Transcatheter Aortic Valve ReplacementHarold L Dauerman, Michael J Reardon, Jeffrey J Popma, et al.
Journal of the American College of Cardiology|January 13, 1998
Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial. EPIC Investigators. Evaluation of IIb/IIIa Platelet Receptor Antagonist 7E3 in Preventing Ischemic ComplicationsM M Khan, S G Ellis, F V Aguirre, et al.
Journal of Thrombosis and Thrombolysis|December 10, 1999
Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarctionN S Kleiman, R P Tracy, J D Talley, et al.
Clinical Cardiology|April 11, 2012
Clinical outcomes of percutaneous interventions in saphenous vein grafts using drug-eluting stents compared to bare-metal stents: a comprehensive meta-analysisof all randomized clinical trialsMahboob Alam, Salman J Bandeali, Salim S Virani, et al.
Pageof 169